I believe they are doing webinar presentations at some stage this week. Perhaps call them and see if you could attend via online ?
The real carrot from the presentation was just how little of the PeriCoach devices they have to sell to break even - somewhere around 8-10,000 of them being very conservative on the profit figures.
The Taiwan distribution deal alone could see them break even, same goes for Brazil or 8-10,000 PeriCoachs. Seeing as they estimate up to $8M in Taiwan (ramp up over 2 years), $4M Brazil and aiming for 50,000 PeriCoachs they are aiming for dividends, not simply break even.
If you look at the share price rally of ISN and compare the 2 markets, product potential being in the mobile health space and timeframe, they are very similar (incontinence actually larger).
Burette is a slow process, but if picked up by a major will bring in huge royalties - we are all confident securing Brazil will lead to this. The PeriCoach is all marketing, and when you have celebrities like Whoopie Goldbery openly speaking about it on national tv, you can see the blue sky potential there.
ALT Price at posting:
2.1¢ Sentiment: Buy Disclosure: Held
